Close

Legal

FDA Issues Public Health Advisory on Cautions for Use of Antidepressants in Adults and Children

The Food and Drug Administration today issued a Public Health Advisory that provides further cautions to physicians, their patients, and families and caregivers of patients about the need to closely monitor both adults and children with depression, especially at the beginning of treatment, or when the doses are changed with either an increase or decrease […]

Read More

The FDA Continues to Affirm Antidepressant Risks First Identified in my 1991 Book Toxic Psychiatry By Peter R. Breggin, M.D. Ithaca, New York www.breggin.com   In 2004 the FDA issued a black box warning about the increased risk of suicidality in children taking the newer antidepressants, including the SSRIs (Prozac, Zoloft, Paxil, Luvox, Celexa, and […]

Read More

Suppressed Paxil suicide data released

Suppressed Paxil Suicide Data Released Expert Calls for Drug Companies to Publish Safety and Efficacy Data February 27, 2006, Ithaca, New York   Ethical Human Psychology and Psychiatry (EHPP) has published an excerpt from a previously sealed product liability report against Glaxo SmithKline (GSK). The medical expert report documents how the company systematically hid and […]

Read More

Paxil suicide product liability case resolved

Paxil Product Liability Suit Resolved   A man with no previous history of violence or suicide drowned himself and his two children in a bathtub after taking two doses of Paxil. Paxil is an antidepressant of the SSRI (selective serotonin reuptake inhibitor) class, which also includes Prozac, Zoloft, Celexa and Luvox.   Psychiatrist Peter R. […]

Read More

Lacuzong v. GlaxoSmithKline

Lacuzong product liability case against GlaxoSmithKline (makers of Paxil®) The suit Lacuzong v. GlaxoSmithKline (GSK) was brought by the widow of a man who drowned their two children and himself in a tub after taking Paxil for three days. The case was “resolved” to the satisfaction of the family; the drug company denied and continues […]

Read More

An Examination of Eli Lilly and Company’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance

A report by Peter R. Breggin, M.D. The British Medical Journal (BMJ) recently received a series of in-house Eli Lilly documents concerning Prozac from an anonymous source. The BMJ then forwarded the documents to other authorities, including Congressman Maurice Hinchey and the FDA. Congressman Hinchey then distributed the documents to other individuals and organizations, including […]

Read More

Dr. Breggin Medical Expert in First Ever Electroshock Malpractice Victory

Jury Awards $635,000 in ECT Malpractice Case Appeals Court Affirms Dr. Breggin’s Testimony In June 2005 in Columbia, South Carolina, a jury awarded $635,000 in a malpractice suit against a psychiatrist who referred a patient for electroshock treatment. The hospital had previously settled for a small amount and the doctor who administered the treatment was […]

Read More

Eli Lily Zyprexa diabetes cases

Eli Lilly Settles Zyprexa/Diabetes Cases for $690 Million On June 15, 2005, Eli Lilly & Co., the manufacturer of the antipsychotic drug Zyprexa, settled an estimated 8,000 lawsuits pending in the United States concerning its alleged failure to warn about the risk of Zyprexa causing diabetes. The company agreed to pay $690 million but denied […]

Read More